Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Imaging findings and therapy response monitoring in chronic sclerodermatous graft-versus-host disease: preliminary data of a simultaneous PET/MRI approach.

Sauter AW, Schmidt H, Mantlik F, Kolb A, Federmann B, Pfannenberg C, Reimold M, Pichler BJ, Bethge W, Horger MS.

Clin Nucl Med. 2013 Aug;38(8):e309-17. doi: 10.1097/RLU.0b013e3182816559.

PMID:
23455525
2.

Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).

Heusch P, Köhler J, Wittsack HJ, Heusner TA, Buchbender C, Poeppel TD, Nensa F, Wetter A, Gauler T, Hartung V, Lanzman RS.

Eur J Radiol. 2013 Nov;82(11):2055-60. doi: 10.1016/j.ejrad.2013.05.027. Epub 2013 Jul 5.

PMID:
23830904
3.

Clinical significance of MRI/(18)F-FDG PET fusion imaging of the spinal cord in patients with cervical compressive myelopathy.

Uchida K, Nakajima H, Okazawa H, Kimura H, Kudo T, Watanabe S, Yoshida A, Baba H.

Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1528-37. Epub 2012 Aug 2.

4.

Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.

Rakheja R, Chandarana H, DeMello L, Jackson K, Geppert C, Faul D, Glielmi C, Friedman KP.

AJR Am J Roentgenol. 2013 Nov;201(5):1115-9. doi: 10.2214/AJR.13.11304.

PMID:
24147485
5.

Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.

Flores LG 2nd, Yeh HH, Soghomonyan S, Young D, Bankson J, Hu Q, Alauddin M, Huff V, Gelovani JG.

Mol Imaging Biol. 2013 Apr;15(2):175-85. doi: 10.1007/s11307-012-0588-5.

6.

Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.

Armbruster M, Sourbron S, Haug A, Zech CJ, Ingrisch M, Auernhammer CJ, Nikolaou K, Paprottka PM, Rist C, Reiser MF, Sommer WH.

Invest Radiol. 2014 Jan;49(1):7-14. doi: 10.1097/RLI.0b013e3182a4eb4a.

PMID:
24002080
7.

Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.

Jena A, Taneja S, Goel R, Renjen P, Negi P.

Eur J Radiol. 2014 Jul;83(7):1269-74. doi: 10.1016/j.ejrad.2014.04.008. Epub 2014 Apr 23.

PMID:
24813529
8.

MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.

Dong A, Dong H, Wang Y, Gong J, Lu J, Zuo C.

Clin Nucl Med. 2013 Feb;38(2):e66-73. doi: 10.1097/RLU.0b013e318266ceca.

PMID:
22996250
9.

Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?

Van den Bergh L, Koole M, Isebaert S, Joniau S, Deroose CM, Oyen R, Lerut E, Budiharto T, Mottaghy F, Bormans G, Van Poppel H, Haustermans K.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1486-92. doi: 10.1016/j.ijrobp.2011.10.046. Epub 2012 Jan 26.

PMID:
22284686
10.

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.

Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.

Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

PMID:
23519008
11.

Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.

Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.

J Nucl Med. 2014 Feb;55(2):191-7. doi: 10.2967/jnumed.113.123646. Epub 2013 Dec 5.

12.

Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR reading.

Schaarschmidt BM, Grueneisen J, Heusch P, Gomez B, Beiderwellen K, Ruhlmann V, Umutlu L, Quick HH, Antoch G, Buchbender C.

Eur J Radiol. 2015 Jul;84(7):1285-92. doi: 10.1016/j.ejrad.2015.04.008. Epub 2015 Apr 18.

PMID:
25975895
13.

Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.

Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K.

Ann Nucl Med. 2008 Jul;22(6):505-12. doi: 10.1007/s12149-008-0135-2. Epub 2008 Aug 1.

PMID:
18670857
14.

Comparison of the accuracy of PET/CT and PET/MRI spatial registration of multiple metastatic lesions.

Rakheja R, DeMello L, Chandarana H, Glielmi C, Geppert C, Faul D, Friedman KP.

AJR Am J Roentgenol. 2013 Nov;201(5):1120-3. doi: 10.2214/AJR.13.11305.

PMID:
24147486
15.

Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.

Lyons K, Seghers V, Sorensen JI, Zhang W, Paldino MJ, Krishnamurthy R, Rohren EM.

AJR Am J Roentgenol. 2015 Nov;205(5):1094-101. doi: 10.2214/AJR.15.14304.

PMID:
26496558
16.

Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.

Sun H, Xin J, Zhang S, Guo Q, Lu Y, Zhai W, Zhao L, Peng W, Wang B.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):898-905. doi: 10.1007/s00259-013-2668-4. Epub 2014 Jan 25.

PMID:
24463908
17.

Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study.

Einspieler I, Thürmel K, Pyka T, Eiber M, Wolfram S, Moog P, Reeps C, Essler M.

Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1012-24. doi: 10.1007/s00259-015-3007-8. Epub 2015 Apr 16.

PMID:
25876704
18.

High-resolution magnetic resonance imaging and 18FDG-PET findings of the cervical spinal cord before and after decompressive surgery in patients with compressive myelopathy.

Uchida K, Nakajima H, Yayama T, Kobayashi S, Shimada S, Tsuchida T, Okazawa H, Mwaka E, Baba H.

Spine (Phila Pa 1976). 2009 May 15;34(11):1185-91. doi: 10.1097/BRS.0b013e31819e2919.

PMID:
19407675
19.

(18)F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease.

Ruhlmann V, Poeppel TD, Brandt AS, Grüneisen J, Ruhlmann M, Theysohn JM, Forsting M, Bockisch A, Umutlu L.

Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1646-52. doi: 10.1007/s00259-016-3351-3. Epub 2016 Mar 11. Erratum in: Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1395.

PMID:
26969347
20.

Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.

Sakane M, Tatsumi M, Kim T, Hori M, Onishi H, Nakamoto A, Eguchi H, Nagano H, Wakasa K, Hatazawa J, Tomiyama N.

Acta Radiol. 2015 Sep;56(9):1034-41. doi: 10.1177/0284185114549825. Epub 2014 Sep 29.

PMID:
25267921

Supplemental Content

Support Center